Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 218, Issue 4, Pages -
Publisher
Rockefeller University Press
Online
2021-02-11
DOI
10.1084/jem.20200712
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy
- (2020) Richard Barrett et al. CURRENT OPINION IN IMMUNOLOGY
- T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting
- (2020) Christopher J. Hanley et al. BRITISH JOURNAL OF CANCER
- Cancer‑associated fibroblast regulation of tumor neo‑angiogenesis as a therapeutic target in cancer (Review)
- (2019) Fang‑Tao Wang et al. Oncology Letters
- Hypoxic cancer–associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling
- (2019) Fernanda G. Kugeratski et al. Science Signaling
- Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?
- (2019) Nina D’Abreo et al. Nature Reviews Clinical Oncology
- The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
- (2019) Lea Monteran et al. Frontiers in Immunology
- Metabolic crosstalk in the breast cancer microenvironment
- (2019) Ana S. Dias et al. EUROPEAN JOURNAL OF CANCER
- Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
- (2018) Ana Costa et al. CANCER CELL
- A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance
- (2018) Joerg Huelsken et al. CELL
- CD10 + GPR77 + Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
- (2018) Shicheng Su et al. CELL
- A peek into cancer-associated fibroblasts: origins, functions and translational impact
- (2018) Valerie S. LeBleu et al. Disease Models & Mechanisms
- Biophysics of Tumor Microenvironment and Cancer Metastasis - A Mini Review
- (2018) Bashar Emon et al. Computational and Structural Biotechnology Journal
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- The clinical promise of immunotherapy in triple-negative breast cancer
- (2018) Praveen Vikas et al. Cancer Management and Research
- Cancer-associated fibroblasts lead tumor invasion through integrin-β3–dependent fibronectin assembly
- (2017) Youmna Attieh et al. JOURNAL OF CELL BIOLOGY
- Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
- (2017) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeted Therapy for Cancer-Associated Fibroblasts: Are We There Yet?
- (2017) Reagan M Barnett et al. JNCI-Journal of the National Cancer Institute
- Pirfenidone normalizes the tumor microenvironment to improve chemotherapy
- (2017) Christiana Polydorou et al. Oncotarget
- Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases
- (2017) Chen Rachman-Tzemah et al. Cell Reports
- Targeted Therapy for Cancer-Associated Fibroblasts: Are We There Yet?
- (2017) Reagan M Barnett et al. JNCI-Journal of the National Cancer Institute
- MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression
- (2017) Jessica L. Christenson et al. Hormones & Cancer
- Cancer-associated fibroblasts support vascular growth through mechanical force
- (2017) Mary Kathryn Sewell-Loftin et al. Scientific Reports
- Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment
- (2016) Jin-Sung Park et al. CANCER CELL
- Hypoxic control of metastasis
- (2016) E. B. Rankin et al. SCIENCE
- Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer
- (2016) Domenico Ribatti et al. Translational Oncology
- PKM2 released by neutrophils at wound site facilitates early wound healing by promoting angiogenesis
- (2016) Yinwei Zhang et al. WOUND REPAIR AND REGENERATION
- Rational design of a protein that binds integrin αvβ3 outside the ligand binding site
- (2016) Ravi Chakra Turaga et al. Nature Communications
- Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer
- (2016) Ken Takai et al. Oncotarget
- Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors
- (2015) Lei Miao et al. JOURNAL OF CONTROLLED RELEASE
- Pyruvate Kinase M2 in Blood Circulation Facilitates Tumor Growth by Promoting Angiogenesis
- (2014) Liangwei Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibroblast heterogeneity in the cancer wound
- (2014) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Extracellular Matrix Modulates Angiogenesis in Physiological and Pathological Conditions
- (2014) Anna Neve et al. Biomed Research International
- Stromally Derived Lysyl Oxidase Promotes Metastasis of Transforming Growth Factor- -Deficient Mouse Mammary Carcinomas
- (2013) M. W. Pickup et al. CANCER RESEARCH
- Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer
- (2013) FANG JI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis
- (2013) Kun Zhang et al. NATURE CELL BIOLOGY
- Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts
- (2013) Fernando Calvo et al. NATURE CELL BIOLOGY
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Angiogenic properties of myofibroblasts isolated from normal human skin wounds
- (2012) Dominique Mayrand et al. ANGIOGENESIS
- The prognostic value of tumour-stroma ratio in triple-negative breast cancer
- (2012) A.M. Moorman et al. EJSO
- Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis
- (2012) Carmen Chak-Lui Wong et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Myofibroblast-derived PDGF-BB promotes hedgehog survival signaling in cholangiocarcinoma cells
- (2011) Christian D. Fingas et al. HEPATOLOGY
- Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance
- (2011) Rabab A A Mohammed et al. MODERN PATHOLOGY
- Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer
- (2011) Joyce O'Shaughnessy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
- (2011) C. C.-L. Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients
- (2010) Esther M. de Kruijf et al. BREAST CANCER RESEARCH AND TREATMENT
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
- (2009) B. K. Linderholm et al. ANNALS OF ONCOLOGY
- Fibronectin fibrillogenesis regulates three-dimensional neovessel formation
- (2008) X. Zhou et al. GENES & DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation